It looks like you are visiting CMR Surgical from the United States of America.
Please select the following:

I am a US healthcare professional practicing in the United States of America I am NOT a US healthcare professional practicing in the United States of America
December 13, 2017
CMR named one of 2017’s ‘Fierce 15’ medtech companies
December 13, 2017
CMR named one of 2017’s ‘Fierce 15’ medtech companies

Cambridge, UK, 22 September 2017 | CMR Surgical has been named as one of 2017’s Fierce 15 medtech companies by leading industry title Fierce MedTech, for reimagining minimally invasive robotic surgery. The article notes CMR’s desire to extend robotic surgery to become routine through the delivery of a small, modular robotic platform, delivered as a service.

Press Office

T: +44 01223 755801

This news follows CMR being named as one of the UK’s top 10 business disruptors to watch in the 21st annual Sunday Times Virgin Fast Track 10 league table that identified some of the UK’s most disruptive private companies. The 10 companies are recognised for having a business model, product or service that is creating a new market, or transforming existing markets and rapidly taking market share from competitors. CMR has developed Versius, a surgical robot designed to meet the complex requirements of laparoscopic surgery and has filed more than 150 patents throughout its development.

Martin Frost, CEO, CMR Surgical said: “We are on the brink of a revolution in surgical robotics and we are honoured to have been named as a med tech disruptor by both the Sunday Times Virgin Fast Track and Fierce MedTech. This is an exciting time to be a med tech company and we expect the launch of Versius next year to be a real game-changer for the industry, surgeons and patients.”

To read about this year’s listed companies, click here: FierceMedTech’s 2017 Fierce 15


About CMR Surgical Limited

CMR Surgical is a private, British, company developing the next-generation universal robotic system, Versius®, for minimal access (or “keyhole”) surgery.

The vision behind CMR is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics and addressing the six million people who still undergo open surgery each year.

Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1

CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.

About the CMR surgical robotic system

Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily in the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort.  Intended to be used across a range of surgical specialties, the versatility and portability of Versius – enabled by a unique and patented four-axis wrist joint – expands the potential for higher utilisation. This allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.

1 Industry Forecast, Accuray Research